Literature DB >> 6347228

Uses and abuses of analysis of variance.

S J Evans.   

Abstract

Analysis of variance is a term often quoted to explain the analysis of data in experiments and clinical trials. The relevance of its methodology to clinical trials is shown and an explanation of the principles of the technique is given. The assumptions necessary are examined and the problems caused by their violation are discussed. The dangers of misuse are given with some suggestions for alternative approaches.

Mesh：

Year:  1983        PMID： 6347228      PMCID： PMC1427919          DOI： 10.1111/j.1365-2125.1983.tb01544.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


  8 in total

1.  The maximum F-ratio as a short-cut test for heterogeneity of variance.

Authors:  H O HARTLEY
Journal:  Biometrika       Date:  1950-12       Impact factor: 2.445

2.  The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials.

Authors:  J A Freiman; T C Chalmers; H Smith; R R Kuebler
Journal:  N Engl J Med       Date:  1978-09-28       Impact factor: 91.245

3.  The two-period cross-over clinical trial.

Authors:  M Hills; P Armitage
Journal:  Br J Clin Pharmacol       Date:  1979-07       Impact factor: 4.335

4.  Statistical significance tests.

Authors:  D R Cox
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

5.  Measurement in clinical trials.

Authors:  D M Chaput de Saintonge; D W Vere
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

6.  Logic and inference in clinical trials.

Authors:  D W Vere
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

7.  Simultaneous inference in epidemiological studies.

Authors:  D R Jones; L Rushton
Journal:  Int J Epidemiol       Date:  1982-09       Impact factor: 7.196

8.  What can we do with the data we throw away?

Authors:  S J Evans
Journal:  Br J Clin Pharmacol       Date:  1982-11       Impact factor: 4.335
  8 in total
  3 in total

1.  A double blind, randomised, multicentre comparison of two doses of intravenous iloprost in the treatment of Raynaud's phenomenon secondary to connective tissue diseases.

Authors:  H I Torley; R Madhok; H A Capell; R M Brouwer; P J Maddison; C M Black; H Englert; J A Dormandy; H R Watson
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

2.  Between-subject and within-subject variations in the pharmacokinetics of ethanol.

Authors:  A W Jones; K A Jönsson
Journal:  Br J Clin Pharmacol       Date:  1994-05       Impact factor: 4.335

3.  Development of a Novel X-ray Compatible 3D-Printed Bone Model to Characterize Different K-Wire Fixation Methods in Support of the Treatment of Pediatric Radius Fractures.

Authors:  Anna Gabriella Lamberti; Zoltan Ujfalusi; Roland Told; Dániel Hanna; Gergő Józsa; Péter Maróti
Journal:  Polymers (Basel)       Date:  2021-11-29       Impact factor: 4.329
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.